Insider plans sale of 4,698 AGX shares (NYSE: AGX) after recent option exercises

Rhea-AI Filing Summary

Argan, Inc. (AGX) reported a Form 144 notice indicating proposed insider sales. The filing lists 4,698 shares under "Securities To Be Sold" (dated 04/21/2026) and shows three reported sales during the prior three months: 5,000 (01/27/2026), 4,556 (03/31/2026), and 3,636 (04/21/2026).

The transactions are linked to option exercise/equity grant activity and identify Charles Schwab & Co. as the broker. The filing provides contact details for the selling party, John R. Jeffrey, Jr., and lists the exchange as NYSE.

Insights

Corporate Governance Analyst

Form 144 flags a sequence of insider dispositions totaling several thousand shares across Q1–Q2 2026.

The notice lists 4,698 shares as "Securities To Be Sold" on 04/21/2026 and records three prior sales: 5,000, 4,556, and 3,636 on the dates shown. The entries reference an option exercise and an equity grant, indicating exercises followed by dispositions.

Cash‑flow treatment and intended sale methods are not detailed in the excerpt. Subsequent filings or broker reports would clarify whether these are open‑market sales, Rule 144 qualified resales, or programmatic dispositions.

Key Figures

Planned sale listed: 4,698 shares Sale recorded (Jan): 5,000 shares Sale recorded (Mar): 4,556 shares +1 more

4 metrics

Planned sale listed 4,698 shares Securities To Be Sold dated 04/21/2026

Sale recorded (Jan) 5,000 shares Sale dated 01/27/2026 reported for John R. Jeffrey, Jr.

Sale recorded (Mar) 4,556 shares Sale dated 03/31/2026 reported for John R. Jeffrey, Jr.

Sale recorded (Apr) 3,636 shares Sale dated 04/21/2026 reported for John R. Jeffrey, Jr.

Key Terms

Form 144, EQUITY GRANT, OPTION EXERCISE, Securities To Be Sold

4 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

EQUITY GRANT financial

"04/21/2026 | EQUITY GRANT | Issuer"

OPTION EXERCISE financial

"04/21/2026 | OPTION EXERCISE"

Securities To Be Sold regulatory

"144: Securities To Be Sold"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Charles Schwab & Co. Inc. 3000 Schwab Way Westlake TX 76262	2698	1781975.04	13945962	04/27/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	04/21/2026	EQUITY GRANT	Issuer			4698	04/21/2026	OPTION EXERCISE

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
John R. Jeffrey, Jr. c/o Argan, Inc. 4075 Wilson Blvd, Suite 440 Arlington VA 22203	Common Stock	01/27/2026	5000	1803900
John R. Jeffrey, Jr. c/o Argan, Inc. 4075 Wilson Blvd, Suite 440 Arlington VA 22203	Common Stock	03/31/2026	4556	2459556.60
John R. Jeffrey, Jr. c/o Argan, Inc. 4075 Wilson Blvd, Suite 440 Arlington VA 22203	Common Stock	04/21/2026	3636	2237594.40

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does AGX's Form 144 disclose about planned insider sales?

It states a proposed sale of 4,698 shares dated 04/21/2026. The excerpt also lists three prior dispositions of 5,000, 4,556, and 3,636 shares in Q1–Q2 2026.

Who is listed as the selling party on the AGX Form 144?

The notice lists John R. Jeffrey, Jr. with a c/o Argan, Inc. address. Contact and broker details include Charles Schwab & Co. Inc. at the address shown in the filing.

Are the AGX transactions linked to option exercises or grants?

Yes. The filing references an EQUITY GRANT and an OPTION EXERCISE on 04/21/2026, which correspond to the listed securities to be sold and the recorded sales.

Does the Form 144 show how the AGX shares will be sold?

The excerpt does not specify sale methods. It lists quantities and dates but does not state whether sales are open‑market, brokered, or otherwise arranged in this excerpt.

What recent insider sales by AGX are recorded in the filing?

Three recent dispositions are recorded: 5,000 shares on 01/27/2026, 4,556 shares on 03/31/2026, and 3,636 shares on 04/21/2026 as shown in the filing.